Diabetes Burden and Prevention

Diabetes Canada estimates that, as of 2015, 3.4 million Canadians (9.3% of the population) have type 2 diabetes—a number they expect will increase by 2025, when a predicted 5 million Canadians (12.1% of the population) will suffer from the disease.

The pervasiveness of diabetes is amplified by its side effects, including: cardiovascular complications, end-stage renal disease, and lower limb amputation are all corollary to untreated, debilitating diabetes.

The already-widespread, but still growing prevalence of diabetes, and the variety of complications it incurs, demand a rigorous investigation into its social, cultural and environmental causes. Our team leads a number of research studies related to the health and economic burden of type 2 diabetes.

To learn more about our work in Diabetes Burden and Prevention, please see the following resources:

• Rosella LC, Negatu E, Kornas K, Chu C, Zhou L, Buajitti E. Multimorbidity at time of death among persons with type 2 diabetes: A population-based study in Ontario, Canada. BMC Endocrine Disorders. 2023. In press.
• Hillmer M, Sandoval GA, Elliott JA, Jain M, Barker T, Prisniak A, Astley S, Rosella LC. Diabetes risk reduction in primary care: Evaluation of the Ontario Primary Care Diabetes Prevention Program. Canadian Journal of Public Health. 2017; 108(2): e176-e184. Available at: https://journal.cpha.ca/index.php/cjph/article/view/5287
• Zuk A, Quiñonez C, Lebenbaum M, Rosella LC. The Association between Undiagnosed Glycemic Abnormalities and Cardiometabolic Risk Factors with Periodontitis: Results from 2007-2009 Canadian Health Measures Survey. Journal of Clinical Periodontology. 2016;44(2):132-141. Available at: http://onlinelibrary.wiley.com/doi/10.1111/jcpe.12684/abstract.
• Campbell TK, Alberga A, Rosella LC. The impact of access to health services on prediabetes awareness: A population-based study. Preventive Medicine. 2016; 93(7): 7-13. Available at: https://www.ncbi.nlm.nih.gov/pubmed/27612580.
• Rosella LC, Lebenbaum M, Fitzpatrick T, O’Riley D, Wang J, Booth GL, Stukel TA, Wodchis W. Impact of diabetes on healthcare costs in a population-based cohort: A cost analysis. Diabetic Medicine. 2016; 33(3): 395-403. Available at: https://www.ncbi.nlm.nih.gov/pubmed/26201986.
• Zuk A, Fitzpatrick T, Rosella LC. Effect of vitamin D3 supplementation on inflammatory markers and glycemic measures among overweight or obese adults: A systematic review of randomized controlled trials. e0154215. Available at: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0154215.
• Rosella LC, Lebenbaum M, Fitzpatrick T, Zuk A, Booth G. The prevalence of prediabetes and undiagnosed diabetes in Canada (2007-2011): According to fasting plasma glucose and HbA1c screening criteria. Diabetes Care. 2015; 38(7): 1299-1305. Available at: http://care.diabetesjournals.org/content/38/7/1299.long.